Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

RVMD Revolution Medicines

19.721
+0.191+0.98%
Trading Session 10/04 10:31 ET
High
20.490
Open
19.980
Turnover
1.50M
Low
19.721
Pre Close
19.530
Volume
74.84K
Market Cap
1.73B
P/E(TTM)
Loss
52wk High
34.160
Shares
87.70M
P/E(Static)
Loss
52wk Low
14.080
Float Cap
1.39B
Bid/Ask %
-33.33%
Historical High
56.180
Shs Float
70.68M
Volume Ratio
0.66
Historical Low
14.080
Dividend TTM
--
Div Yield TTM
--
P/B
3.47
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.11%
Amplitude
3.94%
Avg Price
20.103
Lot Size
1
Float Cap
1.39B
Bid/Ask %
-33.33%
Historical High
56.180
Shs Float
70.68M
Volume Ratio
0.66
Historical Low
14.080
Dividend TTM
--
P/B
3.47
Dividend LFY
--
Turnover Ratio
0.11%
Amplitude
3.94%
Avg Price
20.103
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Revolution Medicines, Inc. is a clinical-stage precision oncology company focused on developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.
CEO: Dr. Mark A. Goldsmith, M.D., PhD
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...